What is Biotechware?
Biotechware is at the forefront of revolutionizing cardiovascular diagnostic assistance. The company offers a holistic suite of digital health and telemedicine solutions designed for comprehensive screening, diagnosis, and monitoring of cardiac conditions. Their advanced product portfolio includes the TrAIcorder for contactless cardiometabolic screening, CardioPad Lite for efficient ECG data acquisition, and Eclipse PRO for dynamic ECG recording. Biotechware serves a broad spectrum of clients, including hospitals, clinics, pharmacies, healthcare professionals, patients, and institutions, ensuring the delivery of rapid and reliable diagnostic services. The company's commitment to quality, speed, and security is further evidenced by its 24/7 support and adherence to ISO and GDPR standards, positioning it as a key player in the health technology market.
How much funding has Biotechware raised?
Biotechware has raised a total of $2.4M across 1 funding round:
Private Equity
$2.4M
Private Equity (2017): $2.4M with participation from MEDME Group
Key Investors in Biotechware
MEDME Group
MEDME Group, operating through its domain medme.com, appears to be involved in technology and media news, potentially offering services related to domain registration and hosting. Their participation suggests an interest in supporting companies with a strong digital presence and technological innovation.
What's next for Biotechware?
With a substantial enterprise-level funding round and a recent strategic investment, Biotechware is poised for significant scaling and innovation. The capital infusion is likely to accelerate the development of new diagnostic tools, enhance their existing product lines, and expand their market reach both domestically and internationally. Future endeavors may include strategic partnerships with larger healthcare networks, further integration of AI into their diagnostic platforms, and potentially exploring new therapeutic areas within cardiovascular health. The company's focus on telemedicine solutions also positions it favorably to capitalize on the growing trend of remote patient monitoring and digital healthcare services.
See full Biotechware company page
